Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Abdominal Cancer
10%
Adjuvant Chemotherapy
22%
Androgen Receptor
15%
Anthracycline
11%
Bone Metastasis
16%
Brain Metastasis
16%
Breast
11%
Breast Cancer
100%
Clear Cell Renal Cell Carcinoma
11%
Clinical Feature
14%
Disease Free Survival
19%
Epidermal Growth Factor Receptor
23%
Epidermal Growth Factor Receptor 2
12%
Fluorodeoxyglucose F 18
21%
Gamma Urogastrone
24%
Gene Expression
13%
Glucose Transporter 1
10%
Hazard Ratio
18%
Hormone Receptor
11%
Hormone Therapy
11%
Immunohistochemistry
13%
Inpatient
22%
Lung Adenocarcinoma
16%
Lung Cancer
18%
Lymphocyte
30%
Lymphocyte
13%
Lymphovascular Invasion
10%
Malignant Neoplasm
14%
Metastatic Breast Cancer
47%
Neoadjuvant Chemotherapy
14%
Neoplasm
36%
Neutrophil
14%
Neutrophil
13%
Next Generation Sequencing
32%
Non Small Cell Lung Cancer
19%
Onset Age
21%
Overall Survival
57%
Palbociclib
16%
Patient
33%
Positron Emission Tomography-Computed Tomography
16%
Prognostic Factor
11%
Programmed Death 1 Ligand 1
10%
Progression Free Survival
39%
Receptor Subtype
13%
Recurrence Free Survival
15%
Small Cell Lung Cancer
14%
Survival
14%
Trastuzumab
14%
Triple Negative Breast Cancer
43%
Tumor Infiltrating Lymphocyte
23%
Pharmacology, Toxicology and Pharmaceutical Science
Anthracycline
16%
Antibiotics
10%
Atezolizumab
10%
Bone Metastasis
10%
Breast Cancer
28%
Capecitabine
20%
Carcinoembryonic Antigen
10%
Carcinoembryonic Antigen
7%
Cardiotoxicity
12%
Chemotherapy
36%
Cisplatin
41%
Diseases
8%
Doxorubicin
20%
Epidermal Growth Factor Receptor
11%
Epidermal Growth Factor Receptor Kinase Inhibitor
10%
Epithelium Tumor
10%
Fluorodeoxyglucose F 18
10%
Gamma Urogastrone
18%
Gemcitabine
12%
Gemcitabine
10%
Glucose Transporter 1
10%
Hormone Receptor
17%
Immune Checkpoint Inhibitor
11%
Intraductal Carcinoma
10%
Letrozole
8%
Listeria monocytogenes
10%
Meningoencephalitis
10%
Metastatic Breast Cancer
48%
Metastatic Colorectal Cancer
10%
microRNA
8%
Monotherapy
12%
Neoplasm
15%
Neoplasm
9%
Neutropenia
11%
Non Small Cell Lung Cancer
17%
Overall Survival
45%
Overall Survival
13%
Paclitaxel
12%
Palbociclib
21%
Phase II Trials
10%
Platinum
6%
Progression Free Survival
30%
Recurrent Disease
11%
Retrospective Study
10%
Small Cell Lung Cancer
10%
Taxane
16%
Toxicity
6%
Transforming Growth Factor Beta
10%
Trastuzumab
6%
Triple Negative Breast Cancer
28%
Biochemistry, Genetics and Molecular Biology
Age
5%
Androgen Receptor
5%
Angiogenesis
6%
Angiogenesis
5%
Anthracycline
5%
Antibiotic Sensitivity
10%
BRCA1
6%
Cancer Cell
8%
Cancer Staging
5%
Capecitabine
10%
Carcinogenesis
8%
Carvedilol
5%
Case Report
5%
Circulating Tumor DNA
6%
Colon
13%
Disease Free Survival
10%
Doxorubicin
5%
Epidermal Growth Factor Receptor
17%
Escherichia coli
5%
Escherichia coli
5%
Fusion Gene
10%
Gene Expression Data
7%
Gene Mutation
9%
Genetic Screening
6%
Germ Cell
12%
Germline
12%
Homologous Recombination
12%
Homologous Recombination
5%
Immune Checkpoints
5%
Immunostaining
9%
KIF5B
10%
KRAS
10%
Mutated Genes
5%
Neutrophil-To-Lymphocyte Ratio
5%
Next Generation Sequencing
20%
NLRP2
5%
Overall Survival
23%
PD-L1
7%
Phase II Trials
6%
Phenol Red
6%
Phylogeny
5%
Plasmid
5%
Progression Free Survival
7%
Saponin
5%
Saponin
5%
SOX2
16%
Tumor Gene
10%
Tumor Gene
10%
Tumor-Infiltrating Lymphocytes
5%
Whole Genome Sequencing
10%
